526
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Diazoxide may protect endothelial glycocalyx integrity during coronary artery bypass grafting

, , , , , , , & show all
Pages 339-344 | Received 10 Jul 2012, Accepted 26 Jul 2012, Published online: 31 Aug 2012

Figures & data

Figure 1. Representative electron microscopy of right atrium before (A) and during (B) coronary artery bypass grafting (CABG). Note injured and swollen mitochondria indicating ischemia and edema shown with arrows in B.

Figure 1. Representative electron microscopy of right atrium before (A) and during (B) coronary artery bypass grafting (CABG). Note injured and swollen mitochondria indicating ischemia and edema shown with arrows in B.

Figure 2. Syndecan-1 fold change concentrations adjusted to base line before coronary artery bypass grafting (Citation1), immediately after aortic declamping (Citation2) and after operation (Citation3) in controls (A, open circles) and in patients with Diazoxide (B, black triangles). Median is shown in each group with a horizontal line. An interpolation line has been added between median markers. Note significant increase (p < 0.004) and decrease (p < 0.04) from base line to time points 2 and 3, respectively, in patients with Diazoxide (B).

Figure 2. Syndecan-1 fold change concentrations adjusted to base line before coronary artery bypass grafting (Citation1), immediately after aortic declamping (Citation2) and after operation (Citation3) in controls (A, open circles) and in patients with Diazoxide (B, black triangles). Median is shown in each group with a horizontal line. An interpolation line has been added between median markers. Note significant increase (p < 0.004) and decrease (p < 0.04) from base line to time points 2 and 3, respectively, in patients with Diazoxide (B).

Figure 3. Hyaluronan fold change concentrations adjusted to base line before coronary artery bypass grafting (Citation1), immediately after aortic declamping (Citation2) and after operation (Citation3) in controls (A, open circles) and in patients with Diazoxide (B, black triangles). Median is shown in each group with a horizontal line. An interpolation line has been added between median markers. In both controls and patients with Diazoxide, an increase of Hyaluronan was noted at time point 2. Note significant decrease (p < 0.04) from time point 2 to 3 in patients with Diazoxide (B) but not controls (A).

Figure 3. Hyaluronan fold change concentrations adjusted to base line before coronary artery bypass grafting (Citation1), immediately after aortic declamping (Citation2) and after operation (Citation3) in controls (A, open circles) and in patients with Diazoxide (B, black triangles). Median is shown in each group with a horizontal line. An interpolation line has been added between median markers. In both controls and patients with Diazoxide, an increase of Hyaluronan was noted at time point 2. Note significant decrease (p < 0.04) from time point 2 to 3 in patients with Diazoxide (B) but not controls (A).

Figure 4. Correlation of Hyaluronan and syndecan-1 fold change values adjusted to base line for controls (A) and patients with Diazoxide (B). Note controlled correlation in B for patients with Diazoxide (R2 linear = 0.654, p < 0.005), but not for controls (R2 linear = 0.017, ns).

Figure 4. Correlation of Hyaluronan and syndecan-1 fold change values adjusted to base line for controls (A) and patients with Diazoxide (B). Note controlled correlation in B for patients with Diazoxide (R2 linear = 0.654, p < 0.005), but not for controls (R2 linear = 0.017, ns).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.